Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Total Current Assets : £2.79 Mil (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Oxford Cannabinoid Technologies Holdings's total current assets for the quarter that ended in Oct. 2023 was £2.79 Mil.

Oxford Cannabinoid Technologies Holdings Total Current Assets Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Total Current Assets Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

Total Current Assets

0.25

2.26

1.04

15.05

4.49

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
Total Current Assets	Get a 7-Day Free Trial				15.05	12.86	7.40	4.49	2.79

Oxford Cannabinoid Technologies Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Oxford Cannabinoid Technologies Holdings's Total Current Assets for the fiscal year that ended in Apr. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2.297	+	0.301	+	0	+	1.89
	=	4.49

Oxford Cannabinoid Technologies Holdings's Total Current Assets for the quarter that ended in Oct. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.134	+	1.656	+	0	+	0
	=	2.79

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Oxford Cannabinoid Technologies Holdings's Liquidation Value for the quarter that ended in Oct. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.134	-	0.84	+	0.75 * 1.656	+	0.5 * 0
=	1.54

Oxford Cannabinoid Technologies Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

0CB:Germany

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines